JPWO2020200241A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020200241A5 JPWO2020200241A5 JP2021560499A JP2021560499A JPWO2020200241A5 JP WO2020200241 A5 JPWO2020200241 A5 JP WO2020200241A5 JP 2021560499 A JP2021560499 A JP 2021560499A JP 2021560499 A JP2021560499 A JP 2021560499A JP WO2020200241 A5 JPWO2020200241 A5 JP WO2020200241A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- amd
- diabetic retinopathy
- age
- macular degeneration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010012689 Diabetic retinopathy Diseases 0.000 claims description 18
- 206010064930 age-related macular degeneration Diseases 0.000 claims description 12
- 208000002780 macular degeneration Diseases 0.000 claims description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 208000001344 Macular Edema Diseases 0.000 claims description 6
- 206010025415 Macular oedema Diseases 0.000 claims description 6
- 201000007917 background diabetic retinopathy Diseases 0.000 claims description 6
- 208000030533 eye disease Diseases 0.000 claims description 6
- 201000010230 macular retinal edema Diseases 0.000 claims description 6
- 208000000208 Wet Macular Degeneration Diseases 0.000 claims description 4
- GYSCAQFHASJXRS-FFCOJMSVSA-N beauvericin Chemical compound C([C@H]1C(=O)O[C@@H](C(N(C)[C@@H](CC=2C=CC=CC=2)C(=O)O[C@@H](C(=O)N(C)[C@@H](CC=2C=CC=CC=2)C(=O)O[C@@H](C(=O)N1C)C(C)C)C(C)C)=O)C(C)C)C1=CC=CC=C1 GYSCAQFHASJXRS-FFCOJMSVSA-N 0.000 claims description 4
- GYSCAQFHASJXRS-UHFFFAOYSA-N beauvericin Natural products CN1C(=O)C(C(C)C)OC(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C(C(C)C)OC(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C(C(C)C)OC(=O)C1CC1=CC=CC=C1 GYSCAQFHASJXRS-UHFFFAOYSA-N 0.000 claims description 4
- 108010079684 beauvericin Proteins 0.000 claims description 4
- 206010029113 Neovascularisation Diseases 0.000 claims description 3
- 208000022873 Ocular disease Diseases 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962828616P | 2019-04-03 | 2019-04-03 | |
| US62/828,616 | 2019-04-03 | ||
| US201962899279P | 2019-09-12 | 2019-09-12 | |
| US62/899,279 | 2019-09-12 | ||
| PCT/CN2020/082765 WO2020200241A1 (en) | 2019-04-03 | 2020-04-01 | Method for treating ocular diseases |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022528566A JP2022528566A (ja) | 2022-06-14 |
| JP2022528566A5 JP2022528566A5 (https=) | 2022-09-06 |
| JPWO2020200241A5 true JPWO2020200241A5 (https=) | 2022-09-06 |
| JP7461663B2 JP7461663B2 (ja) | 2024-04-04 |
Family
ID=72662774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560499A Active JP7461663B2 (ja) | 2019-04-03 | 2020-04-01 | 眼疾患の処置方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11033603B2 (https=) |
| EP (1) | EP3946414B1 (https=) |
| JP (1) | JP7461663B2 (https=) |
| KR (1) | KR20210149087A (https=) |
| CN (1) | CN113795268B (https=) |
| SG (1) | SG11202110659SA (https=) |
| TW (1) | TWI818168B (https=) |
| WO (1) | WO2020200241A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI788083B (zh) * | 2021-11-03 | 2022-12-21 | 葡萄王生技股份有限公司 | 蟬花菌絲體活性物質用於治療黃斑部病變之用途 |
| CN120936366A (zh) * | 2023-03-20 | 2025-11-11 | 资元堂生物科技股份有限公司 | 一种白殭菌素用于制备抑制血管新生药物的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0327316A (ja) * | 1989-06-23 | 1991-02-05 | Kitasato Inst:The | 高脂血症治療剤 |
| KR20080031474A (ko) * | 2005-07-27 | 2008-04-08 | 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. | 안구 질환의 치료를 위한 열충격의 사용 |
| CN101669939A (zh) * | 2009-09-22 | 2010-03-17 | 中山大学 | 恩镰孢菌素类化合物在制备抗耐药结核菌药物中的应用 |
| US20140275091A1 (en) * | 2013-03-15 | 2014-09-18 | Coyote Pharmaceuticals, Inc. | Ocular formulations comprising geranylgeranylacetone derivatives for intraocular delivery |
| US20140371158A1 (en) * | 2013-06-14 | 2014-12-18 | Georgia Regents University | Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway |
| CN109200066A (zh) * | 2017-07-07 | 2019-01-15 | 葡萄王生技股份有限公司 | 蝉花活性物质及其用于预防、延缓或治疗白内障的用途 |
-
2020
- 2020-04-01 CN CN202080025566.3A patent/CN113795268B/zh active Active
- 2020-04-01 WO PCT/CN2020/082765 patent/WO2020200241A1/en not_active Ceased
- 2020-04-01 US US16/837,259 patent/US11033603B2/en active Active
- 2020-04-01 TW TW109111356A patent/TWI818168B/zh active
- 2020-04-01 EP EP20782491.3A patent/EP3946414B1/en active Active
- 2020-04-01 JP JP2021560499A patent/JP7461663B2/ja active Active
- 2020-04-01 SG SG11202110659SA patent/SG11202110659SA/en unknown
- 2020-04-01 KR KR1020217034481A patent/KR20210149087A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022191257A5 (https=) | ||
| JP2017075173A5 (https=) | ||
| NZ710575A (en) | Pharmaceutical compositions for the treatment of diabetes mellitus | |
| JP2013500977A5 (https=) | ||
| JP2020534270A5 (https=) | ||
| RU2014123472A (ru) | Производные 4-прегенен-11ss-17-21-триол-3,20-диона для лечения глазных болезней | |
| MX2022006439A (es) | Compuestos para el tratamiento de enfermedades oculares asociadas con la vascularizacion excesiva. | |
| RU2013137645A (ru) | Аналоги цистамина, применяемые для лечения болезни паркинсона | |
| JP2022528566A5 (https=) | ||
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| JP2019532026A5 (https=) | ||
| FI2765988T3 (fi) | Silmäkoostumus, joka sisältää bromfenaakkia, jolla on parannettu biologinen hyötyosuus | |
| JP2007527417A5 (https=) | ||
| JPWO2020200241A5 (https=) | ||
| JP2019502719A5 (https=) | ||
| RU2017111579A (ru) | Способы лечения и предотвращения заболеваний глаз, расстройств и патологических состояний меланином и аналогами, предшественниками и производными меланина | |
| JP2020530459A5 (https=) | ||
| JP2017514829A5 (https=) | ||
| JP2021525758A5 (https=) | ||
| Villegas et al. | Herpetic keratitis in a patient who used two different prostaglandin analogue ophthalmic solutions: a case report | |
| JP2021511352A5 (https=) | ||
| RU2010141560A (ru) | Лечение офтальмологических заболеваний | |
| JPWO2020180865A5 (https=) | ||
| Choi et al. | Retinal nerve fiber layer thickness measured by spectral domain optical coherence tomography in healthy Koreans | |
| RU2014106328A (ru) | Фармацевтические композиции, содержащие 4-бром-n-(имидазолидин-2-илиден)-1н-бензимидазол-5-амин для лечения заболеваний сетчатки |